Zhitong Financial APP News, Shanghai Fosun Pharmaceutical (02196) announced the resolution of the board meeting.

The meeting deliberated and adopted a motion on participating in the capital increase of Shanghai Fuyun Health Technology Co., Ltd. It is agreed that the holding subsidiaries Shanghai Fosun Health Technology (Group) Co., Ltd., Ningbo compound Medical Technology Co., Ltd. and Hainan Yunzhi Science and Technology Partnership (limited partnership) jointly increase the capital of Shanghai Fuyun Health Technology Co., Ltd.

Among them: Fosun Health contributed RMB 8.5 million to subscribe for Fuyun Health increased registered capital of 8.5 million yuan, Ningbo compound Technology contributed RMB 8.5 million yuan for Fuyun Health increased registered capital of 8.5 million yuan; in addition, it is agreed that Fosun Health has borrowed from Shanghai Fosun Hi-Tech (Group) Co., Ltd. the principal loan of RMB 25.5 million shall survive after the completion of this capital increase, up to the loan maturity date at the latest.